rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2003-1-10
|
pubmed:abstractText |
Graves' disease (GD) has been reported to be frequently complicated with other autoimmune diseases. However, it is rarely complicated with scleroderma-polymyositis overlap syndrome. Recently, we encountered a 35-year-old woman who developed GD and immune thrombocytopenic purpura during follow-up observation of scleroderma-dermatomyositis overlap syndrome. Platelet counts recovered after high-dose gamma-globulin therapy and bolus methylprednisolone therapy. The present case is the first report of a combination of scleroderma, dermatomyositis, GD, and immune thrombocytopenic purpura. The patient was anti-Ku antibody-positive and had relatively low natural killer T cell counts, both of which might contribute to the complication of multiple autoimmune diseases.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Nuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Antithyroid Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Helicases,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ku autoantigen,
http://linkedlifedata.com/resource/pubmed/chemical/Methimazole,
http://linkedlifedata.com/resource/pubmed/chemical/Propylthiouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Steroids,
http://linkedlifedata.com/resource/pubmed/chemical/XRCC5 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0918-2918
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1199-203
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12521216-Adult,
pubmed-meshheading:12521216-Anti-Inflammatory Agents,
pubmed-meshheading:12521216-Antigens, Nuclear,
pubmed-meshheading:12521216-Antithyroid Agents,
pubmed-meshheading:12521216-Autoantibodies,
pubmed-meshheading:12521216-DNA Helicases,
pubmed-meshheading:12521216-DNA-Binding Proteins,
pubmed-meshheading:12521216-Dermatomyositis,
pubmed-meshheading:12521216-Female,
pubmed-meshheading:12521216-Graves Disease,
pubmed-meshheading:12521216-Humans,
pubmed-meshheading:12521216-Methimazole,
pubmed-meshheading:12521216-Platelet Transfusion,
pubmed-meshheading:12521216-Propylthiouracil,
pubmed-meshheading:12521216-Purpura, Thrombocytopenic, Idiopathic,
pubmed-meshheading:12521216-Scleroderma, Systemic,
pubmed-meshheading:12521216-Steroids
|
pubmed:year |
2002
|
pubmed:articleTitle |
Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves' disease and immune thrombocytopenic purpura.
|
pubmed:affiliation |
Department of Molecular and Internal Medicine, Division of Clinical Medical Science, Programs for Applied Biomedicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima.
|
pubmed:publicationType |
Journal Article,
Case Reports
|